Anaphylactic shock due to patent blue: Four case report and review of literature;Choc anaphylactique et bleu patente: À propos de quatre cas et revue de la littérature

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 39, Issue 2, 2010, Pages 116-120

  Lucas, N ^a   Benay Interne, S ^a   Laine, P ^b   Nicolie, B ^b   Fondrinier, E ^a  

^a CENTRE PAUL PAPIN   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

Allergic reaction; Anaphylactic shock; Breast carcinoma; Patent blue; Sentinel lymph node

Indexed keywords

ADRENALIN; CORTICOSTEROID; DISULFINE BLUE; EPHEDRINE; HISTAMINE; IMMUNOGLOBULIN E; PROSTAGLANDIN F2; SEROTONIN; SUFENTANIL; TECHNETIUM 99M; THROMBOCYTE ACTIVATING FACTOR;

ADULT; ALLERGY; ANAPHYLACTIC SHOCK; ANGIONEUROTIC EDEMA; ARTERIAL PRESSURE; ARTICLE; BRADYCARDIA; BREAST CARCINOMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CANCER SURGERY; CASE REPORT; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG SURVEILLANCE PROGRAM; ERYTHEMA; FEMALE; GANGLION; HEART ARRHYTHMIA; HEMODYNAMICS; HUMAN; LUNG EMBOLISM; MASTECTOMY; OXYGEN SATURATION; POSTOPERATIVE PERIOD; RESUSCITATION; SENTINEL LYMPH NODE BIOPSY; SIDE EFFECT; STAINING; TACHYCARDIA; URTICARIA;

ADULT; ANAPHYLAXIS; BREAST NEOPLASMS; COLORING AGENTS; FEMALE; HUMANS; MIDDLE AGED; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY;

EID: 77949874704     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgyn.2009.10.006     Document Type: Article

References (12)

1. Schwartz GF, Giuliano AE, Veronesi U. Proceedings of the consensus conference on the role of sentinel lymph node biopsy in carcinoma of the breast, April 19-22, 2001, Philadelphia, Pennsylvania. Cancer 2002;94:2542-51.
2. Cimmino VM, Brown AC, Szocik JF, Pass HA, Moline S, De SK, et al. Allergic reactions to isosulfan blue during sentinel node biopsy - a common event. Surgery 2001;130:439-42.
3. Beenen E, de Roy van Zuidewijn DB. Patients blue on patent blue: an adverse reaction during four sentinel node procedures. Surg Oncol 2005;14:151-4.
4. Thevarajah S, Huston TL, Simmons RM. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer. Am J Surg 2005;189:236-9.
5. Dewachter P, Mouton-Faivre C, Benhaijoub A, Abel-Decollogne F, Mertes PM. Anaphylactic reaction to patent blue V after sentinel lymph node biopsy. Acta Anaesthesiol Scand 2006;50:245-7.
6. Mansouri R, Chicken DW, Keshtgar MR. Allergic reactions to patent blue dye. Surg Oncol 2006;15:58.
7. Raut CP, Hunt KK, Akins JS, Daley MD, Ross MI, Singletary SE, et al. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol. Cancer 2005;104:692-9.
8. Montgomery LL, Thorne AC, Van Zee KJ, Fey J, Heerdt AS, Gemignani M, et al. Isosulfan blue dye reactions during sentinel lymph node mapping for breast cancer. Anesth Analg 2002;95:385-8.
9. Albo D, Wayne JD, Hunt KK, Rahlfs TF, Singletary SE, Ames FC, et al. Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg 2001;182:393-8.
10. King TA, Fey JV, Van Zee KJ, Heerdt AS, Gemignani ML, Port ER, et al. A prospective analysis of the effect of blue-dye volume on sentinel lymph node mapping success and incidence of allergic reaction in patients with breast cancer. Ann Surg Oncol 2004;11:535-41.
11. Leong SP, Donegan E, Heffernon W, Dean S, Katz JA. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma. Ann Surg Oncol 2000;7:361-6.
12. Laurie SA, Khan DA, Gruchalla RS, Peters G. Anaphylaxis to isosulfan blue. Ann Allergy Asthma Immunol 2002;88:64-6.